A sus­tain­abil­i­ty rule with direct impact for med­ical devices

From August 2026, the EU’s new Pack­ag­ing and Pack­ag­ing Waste Reg­u­la­tion (PPWR) will reshape how prod­ucts are pack­aged for the Euro­pean mar­ket. For med­ical device man­u­fac­tur­ers, the reg­u­la­tion is more than an envi­ron­men­tal mea­sure. It intro­duces bind­ing pack­ag­ing oblig­a­tions that must be man­aged along­side ster­ile-bar­ri­er per­for­mance, prod­uct safe­ty and com­pli­ance with the med­ical devices reg­u­la­tions (MDR and IVDR).

What applies from 12 August 2026?

The first major com­pli­ance date was 12 August 2026. From that date, each pack­ag­ing type placed on the EU mar­ket for the first time will need an EU dec­la­ra­tion of con­for­mi­ty and sup­port­ing tech­ni­cal doc­u­men­ta­tion. The doc­u­men­ta­tion should demon­strate how the pack­ag­ing meets the rel­e­vant PPWR requirements.

Sub­stance lim­its for lead, cad­mi­um, mer­cury and hexa­va­lent chromi­um apply. The reg­u­la­tion also places restric­tions on inten­tion­al­ly added PFAS in food-con­tact pack­ag­ing, while broad­er EU scruti­ny of sub­stances of con­cern remains rel­e­vant for med­ical device pack­ag­ing strate­gies. Impor­tant­ly, pack­ag­ing law­ful­ly placed on the EU mar­ket before the appli­ca­tion date can gen­er­al­ly remain on the mar­ket. The new oblig­a­tions attach to pack­ag­ing placed on the mar­ket from the appli­ca­tion date forward.

Lim­it­ed relief for con­tact-sen­si­tive packaging

Con­tact-sen­si­tive pri­ma­ry pack­ag­ing, such as ster­ile-bar­ri­er trays, pouch­es and mul­ti­lay­er films, ben­e­fits from lim­it­ed exemp­tions from recy­cla­bil­i­ty per­for­mance grades and min­i­mum recy­cled-con­tent tar­gets. How­ev­er, that relief is not a carve-out. Doc­u­men­ta­tion, con­for­mi­ty assess­ment, sub­stance restric­tions, extend­ed pro­duc­er respon­si­bil­i­ty (EPR), labelling and pack­ag­ing-min­imi­sa­tion duties still apply unless a spe­cif­ic exemp­tion is available.

Clas­si­fi­ca­tion will be the sleep­er risk

The prac­ti­cal chal­lenge is prov­ing which pack­ag­ing qual­i­fies for relief. There is no sim­ple offi­cial test for “con­tact-sen­si­tive” pack­ag­ing. Each pack­ag­ing lay­er should be assessed on its func­tion and intend­ed use. For man­u­fac­tur­ers, the best pro­tec­tion is a clear paper trail. Assess­ments should record the pack­ag­ing lev­el, its func­tion, whether it is in direct con­tact with the device, why an exemp­tion is or is not relied on, and what evi­dence sup­ports the conclusion.

Why the time­line is tight for med­ical device manufacturers

Pack­ag­ing changes in the med­ical device sec­tor are rarely sim­ple. A thin­ner pouch, new mate­r­i­al or small­er car­ton may trig­ger risk assess­ment, pack­ag­ing val­i­da­tion, ster­il­i­sa­tion com­pat­i­bil­i­ty review, shelf-life eval­u­a­tion, trans­port test­ing, pro­duc­tion-line changes and updates to tech­ni­cal doc­u­men­ta­tion. That means PPWR plan­ning should not wait until sus­tain­abil­i­ty or labelling dead­lines arrive. Even where lat­er oblig­a­tions phase in through 2030, 2035 and 2040, the ground­work starts with today’s pack­ag­ing port­fo­lio and val­i­da­tion constraints.

Source: Medtech Insight (an Infor­ma product)

Accom­pa­ny­ing this sub­ject we rec­om­mend the fol­low­ing con­tent on our website